Pantoprazol Nycomed (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Nycomed, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults. GNH USA supplies Pantoprazol Nycomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Nycomed is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for: - Gastro‑oesophageal reflux disease (GERD): relief of heartburn and healing of erosive esophagitis. - Erosive duodenal ulcer: promotes ulcer healing and reduces recurrence. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with this rare endocrine tumor.

Pantoprazol Nycomed is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: gas‑related bloating. - Constipation: infrequent.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): requires immediate medical attention. - Clostridioides difficile‑associated colitis: may present with watery diarrhoea. - Acute interstitial nephritis: renal function monitoring recommended. - Low magnesium levels (hypomagnesemia): can cause muscle cramps or cardiac arrhythmia. - Fracture risk with long‑term use: consider bone health assessment.

Before prescribing Pantoprazol Nycomed, consider the following safety measures: - Assess renal function: dose adjustment may be required in severe renal impairment. - Evaluate hepatic function: use with caution in patients with moderate liver disease. - Review concomitant medications: potential for altered absorption of drugs that require acidic pH. - Monitor long‑term users: assess need for calcium, vitamin D and bone density evaluation. - Store below 25°C: keep in the original packaging, protect from moisture and light.

Pantoprazol Nycomed may interact with several medicines; clinical relevance varies.

Major Interactions (Avoid): - Ketoconazole oral suspension: reduced absorption leading to loss of antifungal efficacy. - Atazanavir (HIV protease inhibitor): markedly decreased plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR‑related bleeding risk. - Digoxin: modest rise in serum levels. - Methotrexate (high‑dose): reduced renal clearance may increase toxicity. - Clopidogrel: potential attenuation of antiplatelet effect.